Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CANB Highest Quarterly Revenues
Twitter Post
https://twitter.com/CanBCorp/status/1526894689747705856?s=20&t=XV_jRPm8tgNp9RixrdyeLw
Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History
https://canbcorp.com/canbcorp-investors.html?qmodStoryID=6278330803449426
Misleading.. Again. CANB Continues to make All the Right Moves, add to the list Record Quarterly Earnings, Impressive.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
THE HIGHEST QUARTERLY REVENUE IN COMPANY HISTORY, Very Impressive Indeed:
Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History
May 18 2022 - 07:26AM
InvestorsHub NewsWire
Alert
Print
Share On Facebook
Strengthened Balance Sheet with Increases to $17.0 Million in Total Assets and $6.2 Million in Stockholders Equity
HICKSVILLE, NY -- May 18, 2022 -- InvestorsHub NewsWire -- Can B Corp. (OTCQB: CANB) (“Can B'' or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, today announced the Company's financial results for the first quarter ended March 31, 2022.
Key Financial Highlights for Q1 2022
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Key Business Highlights for Q1 2022
Solidified and integrated vertical processing capabilities from recent acquisitions
Advanced build-out of first CBD lounge in Miami, Florida
Continuing path for potential NASDAQ up-listing
Management Commentary
Marco Alfonsi, Can B’s Chief Executive Officer, stated, “We are extremely pleased with our tremendous quarterly results, having achieved the highest quarterly revenue in our company history. We generated the $1.9 million in quarterly revenue while reducing our cash burn as demonstrated by the decrease in adjusted EBITDA to $0.9 million. The strategic moves we have made over the past several months have completed our vertical processing capabilities and put us in great position to accelerate our revenue growth and strengthen our balance sheet. This quarter’s results prove our plans are working as our team continues its hard at work integrating and ramping up the various operations to continue this momentum into the future.”
Alfonsi concluded, “Can B is now a full-service hemp-derived cannabinoid company that can facilitate servicing the large box types as well as the boutique vape and smoke store. Our dramatic revenue improvements, coupled with our acquisitions and asset base increases, position us solidly to continue our application process for a NASDA up listing.”
Vertical Processing Capabilities
Secured hemp biomass and winterized crude to create over 13,000 Liters (1 Liter = 1.05 Quarts) of isomers, including Delta-8, with a potential wholesale value exceeding $10 million at today's market price. Can B's late 2021 acquired facilities in Colorado will receive harvested hemp biomass and convert it to winterized crude. These same facilities will then process it to distillate, then to isolate which will be shipped to Company-owned facilities in Florida and Tennessee to produce Delta-8 or other isomers, or to its manufacturing facility in Lacey, Washington for its line of CBD tinctures, salves, gels, and drops. This processing is expected to take 5-6 months to produce 13,000 liters of Delta-8 and other isomers with potential revenue of $10 million.
300,000 Square Foot Facility in McMinnville, Tennessee
Acquisition of Assets from TWS Pharma included leases on a total of 15,000 square foot of facilities located in Mead and Ft. Morgan Colorado.
Acquisition of Assets from Music City Botanicals added additional volume in extraction, isomer lab production, and R&D into the evolving isomer market with such products as Delta-10, CBG, CBN, and CBDA.
Financial Results for the Three Months Ended March 31, 2022:
Revenue: For the three months ended March 31, 2022, revenue was $1.9 million, an increase of $1.6 million, or 606%, compared with $0.3 million for the same period last year. The increase is due to the wind-down of restrictions related to the Covid-19 Pandemic surrounding elective surgeries, enabling an increase in the usage of the Company’s Duramed product lines and ultrasound device associated with patient recovery. Additionally, due to asset acquisitions in 2021, the Company’s Music City Botanical and Botanical Biotech brands related to an increase in sales compared to 2021 of $0.6 million.
Gross Profit: For the three months ended March 31, 2022, gross profit was $0.7 million, an increase of $0.4 million, or 291%, compared with $0.2 million for the same period last year. The resulting gross margin was 36.0%, compared with 75.0% for the same period last year.
Total Operating Expenses: For the three months ended March 31, 2022, total operating expenses were $3.9 million, an increase of $1.8 million, or 91%, compared with $2.0 million for the same period last year, as a direct result of professional fees and other accounting and legal fees related to the Company’s registration statement S-1 filing efforts.
Of note, $2.3 million of the Company's operating expenses for the three months ended March 31, 2022, were non-cash expenses, including depreciation, amortization, and stock-based compensation, compared to $0.5 million for the same period last year.
Operating Loss: For the three months ended March 31, 2022, operating loss was $3.2 million, an increase of $1.4 million, compared with an operating loss of $1.8 million for the same period last year.
Adjusted EBITDA Loss: For the three months ended March 31, 2022, Adjusted EBITDA loss was $0.9 million, a decrease of $0.4 million, or 30%, compared with an Adjusted EBITDA loss of $1.3 million for the same period last year, after deducting non-cash and one-time expenses.
Net Loss: For the three months ended March 31, 2022, net loss was $3.5 million, an increase of $1.3 million, or 60%, compared with $2.2 million for the same period last year. The EPS loss per share for the three months ended March 31, 2022, was ($1.10), compared to ($3.58) for the same period last year.
About Can B Corp.
Can B Corp. (OTCQB: CANB) is a health & wellness company providing the highest quality hemp-derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil, and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B Corp. operates R&D and production facilities in Lacey, WA, and Florida. To learn more about Can B Corp. and our comprehensive line of high-quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook or visit one of the 1,000+ retail outlets that carry Can B Corp. products.
For more information about Can B Corp., please visit: CanBCorp.com
Twitter @CanBCorp
Instagram @canbcorp
Facebook @ Can B Corp
YouTube
Stick a fork in the CANB stuffed pig. After all the RS's its true value is trips. Share holders were so screwed here and no way they could ever get back to even.
USE EXTREME CAUTION!
CANB may need a 3rd RS in the future as this is done.
Peace out
"Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History"
https://ih.advfn.com/stock-market/USOTC/can-b-qb-CANB/stock-news/88146793/can-b-corp-reports-first-quarter-revenue-growth-o
Much, MUCH more to come
NASDAQ
CANB
The Badguy
Come on Market Makers it's time to leave 5 bucks way behind. 6, 7, and 10....its time now
Hawk...first of all I'm on your side on this deal.
Secondly, 4.50 5.50 is Jack shit bro. We need 8 bucks plus to be even before the 15 to 1 jack off split.....so let's keep it going. 10- 15 bucks and I'll ne happy.
Lfgooooooo.
MARCO TIME TO GET TO WORK ON THE STOCK PART.
THW COMPANY IS MAKING TONS OF MONEY I GET IT. HOWEVER, WE NEED THW STOCK TO REFLECT THAT.....
Misleading…Again. CANB hitting a high of $5.50 today. Clearly, Accumulation and Holding Continues by Smart Money.
:
Huge Future for CANB.
No wonder All Eyes are focused on CANB 24/7.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
All CANB bag holders, LOOK OUT BELOW!!!!!!!
True value after both RS's is now .0005 and dropping.
Peace out
Ummm No NASDAQ for this pig with lipstick. Not sure how they keep pulling off RS and RS but real value is now in the trips of this CANB shit show.
Misleading…Again. Accumulation and Holding Continues by Smart Money.
:
Huge Future for CANB.
No wonder All Eyes are focused on CANB 24/7.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
Come on millionaires. Buy some shares; let's get back to the 7-8 $ range. You know who you are. Kick down the money and LFGOOOOOOOO.
CANB desperation setting in. Maybe another RS in the future. CANB may set a record the way its going. Too funny and you can stick a fork in this as its done.
Peace out
Can B invites individuals, institutional investors, advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference
HICKSVILLE, NY -- April 27, 2022 -- InvestorsHub NewsWire -- Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a diversified health and wellness company, is pleased to invite individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.
The next Emerging Growth Conference is presenting on Wednesday, April 27th at 11:30 am EDT. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s CEO Marco Alfonsi in real-time.
Mr. Alfonsi will perform a presentation and may subsequently open the floor for questions. Please ask your questions during the event and Marco will do his best to get through as many of them as possible.
Can B Corp will be presenting at 11:30 am Eastern time for 30 minutes.
Please register here to ensure you are able to attend the conference and receive any updates that are released.
The direct registration link is:
https://goto.webcasts.com/starthere.jsp?ei=1541769&tp_key=abbe1c785f&sti=canb
If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and we will also release a link to that after the event.
All sessions will be conducted through video webcasts and will take place in the Eastern time zone.
About Can B Corp.
Can B Corp. (OTCQB: CANB) is a health & wellness company providing the highest quality hemp-derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil, and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B Corp. operates R&D and production facilities in Lacey, WA, and Florida. To learn more about Can B Corp. and our comprehensive line of high-quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook or visit one of the 1,000+ retail outlets that carry Can B Corp. products.
For more information about Can B Corp., please visit: CanBCorp.com
Twitter @CanBCorp
Instagram @canbcorp
Facebook @ Can B Corp
YouTube
About the Emerging Growth Conference
The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services, and other major announcements to the investment community from the convenience of their office, in a time-efficient manner.
The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.
Look out Belowwwww! Stick a fork in CANB as it is done. Maybe another RS as soon as they are allowed. Too funny they are allowed to do this, but it is the OTC cesspool after all.
Peace out
Great Interview! CANB continues to make All the right moves 2022- And Beyond!
Loved this part;
Our second operating division is the hemp division," continued Alfonsi. "For Q3 we made some major acquisitions," he shared. "We increased our balance sheet assets to over $16 million as of 12-31-2021," said Alfonsi. "We're able to be vertically integrated from biomass and hemp crude thru to isolate, and a full line of retain CBD products and various isomers."
"With our Miami operation, we have modeled a consumption lounge adjacent to our lab production operations and hope to open similar operations in select cities ove the next several months. "Once opened in locations where State and Federal laws allow, you'll be able to purchase CBD, Delta-8, or Delta-10 products, and still have the ability to enjoy them in a lounge, which in the evening will turn into a nightclub with live entertainment," he shared, adding that "the lounge will also serve infused beverages and have that CBD Experience being located adjacent to an actual production lab".
"Our third operating division is Duramed, which is our medical device company," said Alfonsi, before elaborating on the Company's wearable technology. "We are now in Michigan, where we have doubled our business," he shared, adding that the Company is also doing business in New York.
Jolly then commented on the Company's recently announced partnerships with PrimeX and American Development Partners. "In March, we signed the Brazilian Joint Venture with PrimeX," said Alfonsi, adding that CBD was not legal in Brazil until recently. "We have final products that are ready to be shipped to Brazil, and hopefully local physicians will be writing scripts on behalf of our products for their patients."
"With American Development Partners, it is a new concept for us," continued Alfonsi. "We were able to secure the American Development Partners to create and raise up to $200 million to build as many as 50 consumption lounges that are available to be assigned to our labs."
"What kind of new isomers are scheduled to be released within the next few months?" asked Jolly. "Right now we are able to do Delta-8," explained Alfonsi. "CBD is still a very low price, but once you convert that isolate into an isomer the price jumps," he explained, before elaborating on the different isomers. "We've been able to increase our revenues and margins for the simple reason that we are able to create these isomers."
To close the interview, Alfonsi elaborated on the Company's significant growth, and encouraged listeners and shareholders to keep up-to-date on their current plans and projects.
To hear Marco Alfonsi's entire interview, follow the link to the podcast here: https://audioboom.com/posts/8069795-can-b-corp-discusses-2022-growth-opportunities-and-new-partnerships-on-the-stock-day-podcast.
CANB is a real shit show. No trades and its almost 3PM. OUCH!
Wow! That’s Massive Revenue Increase Indeed!
CANB Continues to Impress $$$$$
Nasdaq Bound
:
Revenues increased $2,894,160 from $1,709,669 in 2020 to $4,603,829 in 2021."
"Revenues increased $2,894,160 from $1,709,669 in 2020 to $4,603,829 in 2021."
That’s it?????
Yet the Current Price puts the Market Cap at $17 million???
LMFAO
What is the record for RS's? CANB will break it from the looks of it. How is this even legal as they simply wash, rinse and take share holders funds.
With 2 RS's, CANB will need a 3rd to stay above the NASDAQ number in a little. NASDAQ will never ever EVER happen for the sad OTC scheme.
This is worse then a pig with lipstick.
Peace out
"Revenues increased $2,894,160 from $1,709,669 in 2020 to $4,603,829 in 2021."
https://ih.advfn.com/stock-market/USOTC/can-b-qb-CANB/stock-news/87842647/annual-report-10-k
Tell me how CANB isn't gonna be a big player!
NASDAQ
CANB
The Badguy
"NASDAQ"?
"April 15th"
Came went....Good Friday. GL longs. Hope it works for us. Nay sayers and bears f@#$ off
Man Penny I hope you're wrong about another r/s. Shitnif that happens I'll be a pissed off as you. LFGOOOOOOOO I believe Marco can come through.
Sorry but CANB will need a 3rd RS at some point just to keep the BS charade alive.
Stick a fork in the pig, it done as no one would buy this mess.
Peace out
This Friday is GOOD FRIDAY.
CANB lets make it great.
Misleading, CANB continues to make all the right moves. So much for the going out of business fiasco by end of year.
Smart Money will Patiently Hold and Continue to Accumulate.
Huge Future for CANB.
No wonder All Eyes are focused on CANB 24/7.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
These OTC cesspool type companies exist to take that hard earned money.
I think your question is answered on CANB going to NASDAQ April 1st or April fools day. Not happening with this scheme ever.
Sorry for your losses as they will only grow with this double RS BS company. Stick around for the next dive to 5.00, 4.00, 3.00,,,,,,.
RS, wash, rinse and repeat.
Question for the board. You guys think Friday will happen for CANB????? Or is it a pipe dream that NASDAQ WILL HAPPEN?
Hope the right people are in place for the uplifting. We work our assesnoff for our money to invest in various companies. We can only hope the CANB folks are doing the same to get where we need to be. LFGOOOOOOOO
$103,000,000 market cap. One of those that can drop 90% and it’s still high afterwards.
Caveat emptor on Brazilian deals. Off shore deals have little accountability to them because it’s easy to cheat and hard to enforce.
CBD is everywhere. CBD Lounge in Wynwood Miami is a complete joke. Non dilutive to shareholders is a complete lie. Marco loves to bend shareholders over rheeming them out of their shares by Several Reverse Splits.
CANBD will never see Nasdaq
No accumulation here at all
Any selling pressure and this will be at a buck shortly
CANB will be a powerhouse on the NASDAQ
Patience will prevail
Glad I have the resources and the patience
CANB
NASDAQ
The Badguy
What a trainwreck after another CANB RS. Too funny
Spot On, Huge Future for CANB.
No wonder All Eyes are focused on CANB 24/7.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
Who bought a single CANB share? There goes the Beer money for the day. LOL
April fools day? LOL CANB is not going to NASDAQ.
APRIL 1ST
we say good bye to Penny on this board.
NASDAQ LFG
NASDAQ COMING!
VISION
CANB
The Badguy
NASDAQ Hahahahahahahahhahahahha never ever happen, EVER!
The day CAND gets on NASDAQ is the day I will never post on CANB board again. Mark it as CANB is a joke.
CANB on Nasdaq, too funny
No worries, the dedicated Patience will pay off greatly. love this part of the PR.
Marco Alfonsi, Can B's Chief Executive Officer, stated, "We are very excited for this expansion opportunity, with our first location expected to open in the tourist popular Wynwood section of Miami, Florida in April. Our CBD Lounges will encompass food, drink, and entertainment and highlight our health and wellness CBD products. With ADP, we have a well-recognized and experienced partner sharing our vision to build out our CBD Lounges. We have a plan to roll out a number of locations over the next few years and believe it will be a large contributor of revenue to our company without dilution to our shareholders."
This is like the vending machine PR as it was all a shit show. Said they were bought, paid for and being delivered. No on ever seen a vending machine and imagine they fell off a truck in New Jersey. index finger nose tap,,, wink wink.
Please do not lose more than you can afford to in these OTC cesspool plays as that is what they are.
Peace out
$CANB Can B Corp. and American Development Partners Agree to Finance and Develop CBD Lounges
https://www.accesswire.com/692087/can-b-corp-and-american-development-partners--agree-to-finance-and-develop-cbd-lounges
First Location in Wynwood Section of Miami, Florida Targeted to Open in 2nd Quarter 2022
HICKSVILLE, NY / ACCESSWIRE / March 8, 2022 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a health and wellness company specializing in developing, producing, and selling hemp-derived (non THC) cannabinoid products, is pleased to announce it has executed a definitive agreement with American Development Partners® ("ADP") for the financing and development of CBD Lounges featuring its health and wellness products in a social setting.
In following the format of the original "Lab2" created by Can B Corp in Miami, FL, ADP will finance and develop up to 100 similarly-formatted CBD Lounges, with the first 50 committed to by Can B with an option to develop 50 more, to be operated by the Company or its affiliates and Licensees. Each CBD Lounge is budgeted to have development cost of approximately $4 million, for a total initial commitment from American Development Partners of approximately $200 million and an option for an additional $200 million. The agreement stipulates that ADP will be the exclusive developer of the CBD Lounges during the 10-year term of the agreement. ADP will receive a development fee of 10% of the total development cost for each CBD Lounge. Can B will enter into a 20-year lease for each CBD Lounge developed by ADP. This agreement is non-dilutive to CANB shareholders.
ADP was founded in 1995 and its team almost 600 collective years of experience having deployed over $1 billion REIT and additional private equity. ADP specializes in capital, site selection, design, architecture and engineering, construction and sale-leaseback programs. For a list of ADP clients, please visit https://www.americandevelopmentpartners.com/clients.
Marco Alfonsi, Can B's Chief Executive Officer, stated, "We are very excited for this expansion opportunity, with our first location expected to open in the tourist popular Wynwood section of Miami, Florida in April. Our CBD Lounges will encompass food, drink, and entertainment and highlight our health and wellness CBD products. With ADP, we have a well-recognized and experienced partner sharing our vision to build out our CBD Lounges. We have a plan to roll out a number of locations over the next few years and believe it will be a large contributor of revenue to our company without dilution to our shareholders."
Peter Cantel Director of Communication of American Development Partners, commented, "Our team is always looking to work with exciting growth opportunities, especially with new or emerging concepts. We view Can B's CBD Lounges as just that and are thrilled to partner with Can B to help them build out their vision. The CBD Lounge is a great strategy to highlight their health and wellness products in a relaxed social environment giving consumers the chance to educate and enjoy themselves. We've done a lot of buildouts in healthcare and food hospitality, with clients such as American Family Care, Church's Chicken, and Taco Johns, and are excited to add Can B to our roster of clients."
Followers
|
284
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
30519
|
Created
|
06/18/11
|
Type
|
Free
|
Moderators waterchaser |
These brands include Canbiola, developed for the medical community, Seven Chakras, a spa line, NuWellness for independent Pharmacies and Pure Leaf Oil, their flagship consumer brand.
A growing line of other consumer products are also being developed, with exclusive partner agreements, to sell topical topicals, beverages and ingestible products under the LifeGuard® Brand. The company is launching a full line of Sunscreens, Lip Balms, Replenish Supplements and Water in the summer of 2020. In addition, a line of nutritional supplements called Superfoods, is being readied for a launch at the same time.
Their R&D and production facility is in Lacey WA. There they create, tests, and with a proprietary processes, produce the company’s CBD line of products and private label products to the industry’s highest standards.
CanB owns and operates Green Grow Farms, which is licensed to grow and cultivate Hemp in the State of New York.
Through the Duramed Division, the company offers FDA approved medical devices that alleviate joint, bone and muscle pain from injuries and surgery. Sold through doctors and the medical community, they are considered an important part of the solution to solving the opioid crisis.
http://www.canbcorp.com/
https://canbiola.com
https://duramed.us
https://www.otcmarkets.com/stock/CANB/security
Canbiola, Inc. (OTCQB: CANB) Announces the Formation of a New Wholly Owned Subsidiary- DuraMed, Inc
https://duramed.us
https://www.otcmarkets.com/stock/CANB/news/Canbiola-Inc-OTCQB-CANB-Announces-the-Formation-of-a-New-Wholly-Owned-Subsidiary--DuraMed-Inc?id=216443
SUSTAINED ACOUSTIC MEDICINE (SAMS)
Duramed provides wearable bioelectronic devices for the delivery of sustained acoustic medicine (SAMs). The proprietary miniaturized ultrasound platform is designed for the treatment of acute and chronic musculoskeletal conditions, and clinically proven to enhance tissue recovery, accelerate the natural healing processes, and relieve pain.
The SAM® family of products are the only FDA-cleared wearable devices for multi-hour continuous low intensity ultrasound therapy. SAM has a CE Mark, Canada Licensed, and is a Class II medical device in Malaysia and Singapore.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads